Literature DB >> 25339658

AID-initiated DNA lesions are differentially processed in distinct B cell populations.

Zhangguo Chen1, Sheila Ranganath2, Sawanee S Viboolsittiseri3, Maxwell D Eder3, Xiaomi Chen4, Mihret T Elos3, Shunzong Yuan3, Shunzhong Yuan, Erica Hansen2, Jing H Wang1.   

Abstract

Activation-induced deaminase (AID) initiates U:G mismatches, causing point mutations or DNA double-stranded breaks at Ig loci. How AID-initiated lesions are prevented from inducing genome-wide damage remains elusive. A differential DNA repair mechanism might protect certain non-Ig loci such as c-myc from AID attack. However, determinants regulating such protective mechanisms are largely unknown. To test whether target DNA sequences modulate protective mechanisms via altering the processing manner of AID-initiated lesions, we established a knock-in model by inserting an Sγ2b region, a bona fide AID target, into the first intron of c-myc. Unexpectedly, we found that the inserted S region did not mutate or enhance c-myc genomic instability, due to error-free repair of AID-initiated lesions, in Ag-stimulated germinal center B cells. In contrast, in vitro cytokine-activated B cells display a much higher level of c-myc genomic instability in an AID- and S region-dependent manner. Furthermore, we observe a comparable frequency of AID deamination events between the c-myc intronic sequence and inserted S region in different B cell populations, demonstrating a similar frequency of AID targeting. Thus, our study reveals a clear difference between germinal center and cytokine-activated B cells in their ability to develop genomic instability, attributable to a differential processing of AID-initiated lesions in distinct B cell populations. We propose that locus-specific regulatory mechanisms (e.g., transcription) appear to not only override the effects of S region sequence on AID targeting frequency but also influence the repair manner of AID-initiated lesions.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25339658      PMCID: PMC4239163          DOI: 10.4049/jimmunol.1401549

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  74 in total

Review 1.  DNA targets of AID evolutionary link between antibody somatic hypermutation and class switch recombination.

Authors:  Jason A Hackney; Shahram Misaghi; Kate Senger; Christopher Garris; Yonglian Sun; Maria N Lorenzo; Ali A Zarrin
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

2.  AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations.

Authors:  Davide F Robbiani; Anne Bothmer; Elsa Callen; Bernardo Reina-San-Martin; Yair Dorsett; Simone Difilippantonio; Daniel J Bolland; Hua Tang Chen; Anne E Corcoran; André Nussenzweig; Michel C Nussenzweig
Journal:  Cell       Date:  2008-12-12       Impact factor: 41.582

3.  S region sequence, RNA polymerase II, and histone modifications create chromatin accessibility during class switch recombination.

Authors:  Lili Wang; Robert Wuerffel; Scott Feldman; Ahmed Amine Khamlichi; Amy L Kenter
Journal:  J Exp Med       Date:  2009-07-13       Impact factor: 14.307

4.  Alternative end-joining catalyzes class switch recombination in the absence of both Ku70 and DNA ligase 4.

Authors:  Cristian Boboila; Catherine Yan; Duane R Wesemann; Mila Jankovic; Jing H Wang; John Manis; Andre Nussenzweig; Michel Nussenzweig; Frederick W Alt
Journal:  J Exp Med       Date:  2010-02-08       Impact factor: 14.307

Review 5.  Mechanism and regulation of class switch recombination.

Authors:  Janet Stavnezer; Jeroen E J Guikema; Carol E Schrader
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

6.  Mechanisms promoting translocations in editing and switching peripheral B cells.

Authors:  Jing H Wang; Monica Gostissa; Catherine T Yan; Peter Goff; Thomas Hickernell; Erica Hansen; Simone Difilippantonio; Duane R Wesemann; Ali A Zarrin; Klaus Rajewsky; Andre Nussenzweig; Frederick W Alt
Journal:  Nature       Date:  2009-07-09       Impact factor: 49.962

Review 7.  Balancing AID and DNA repair during somatic hypermutation.

Authors:  Man Liu; David G Schatz
Journal:  Trends Immunol       Date:  2009-03-18       Impact factor: 16.687

8.  A cis-acting diversification activator both necessary and sufficient for AID-mediated hypermutation.

Authors:  Artem Blagodatski; Vera Batrak; Sabine Schmidl; Ulrike Schoetz; Randolph B Caldwell; Hiroshi Arakawa; Jean-Marie Buerstedde
Journal:  PLoS Genet       Date:  2009-01-09       Impact factor: 5.917

9.  Immunoglobulin switch mu sequence causes RNA polymerase II accumulation and reduces dA hypermutation.

Authors:  Deepa Rajagopal; Robert W Maul; Amalendu Ghosh; Tirtha Chakraborty; Ahmed Amine Khamlichi; Ranjan Sen; Patricia J Gearhart
Journal:  J Exp Med       Date:  2009-05-11       Impact factor: 14.307

10.  Attracting AID to targets of somatic hypermutation.

Authors:  Atsushi Tanaka; Hong Ming Shen; Sarayu Ratnam; Prashant Kodgire; Ursula Storb
Journal:  J Exp Med       Date:  2010-01-25       Impact factor: 14.307

View more
  10 in total

1.  TRAF3 Acts as a Checkpoint of B Cell Receptor Signaling to Control Antibody Class Switch Recombination and Anergy.

Authors:  Zhangguo Chen; Alexandra Krinsky; Rachel A Woolaver; Xiaoguang Wang; Samantha M Y Chen; Vince Popolizio; Ping Xie; Jing H Wang
Journal:  J Immunol       Date:  2020-06-26       Impact factor: 5.422

2.  Histone Deacetylase Inhibition Sensitizes PD1 Blockade-Resistant B-cell Lymphomas.

Authors:  Xiaoguang Wang; Brittany C Waschke; Rachel A Woolaver; Zhangguo Chen; Gan Zhang; Anthony D Piscopio; Xuedong Liu; Jing H Wang
Journal:  Cancer Immunol Res       Date:  2019-06-24       Impact factor: 11.151

3.  Efficient AID targeting of switch regions is not sufficient for optimal class switch recombination.

Authors:  Amélie Bonaud; Fabien Lechouane; Sandrine Le Noir; Olivier Monestier; Michel Cogné; Christophe Sirac
Journal:  Nat Commun       Date:  2015-07-06       Impact factor: 14.919

4.  TRAF2 Deficiency in B Cells Impairs CD40-Induced Isotype Switching That Can Be Rescued by Restoring NF-κB1 Activation.

Authors:  Rachel A Woolaver; Xiaoguang Wang; Yonatan Dollin; Ping Xie; Jing H Wang; Zhangguo Chen
Journal:  J Immunol       Date:  2018-10-19       Impact factor: 5.422

5.  Interplay between Target Sequences and Repair Pathways Determines Distinct Outcomes of AID-Initiated Lesions.

Authors:  Zhangguo Chen; Maxwell D Eder; Mihret T Elos; Sawanee S Viboolsittiseri; Xiaomi Chen; Jing H Wang
Journal:  J Immunol       Date:  2016-01-25       Impact factor: 5.422

6.  Imbalanced PTEN and PI3K Signaling Impairs Class Switch Recombination.

Authors:  Zhangguo Chen; Andrew Getahun; Xiaomi Chen; Yonatan Dollin; John C Cambier; Jing H Wang
Journal:  J Immunol       Date:  2015-10-23       Impact factor: 5.422

7.  Unexpected effects of different genetic backgrounds on identification of genomic rearrangements via whole-genome next generation sequencing.

Authors:  Zhangguo Chen; Katherine Gowan; Sonia M Leach; Sawanee S Viboolsittiseri; Ameet K Mishra; Tanya Kadoishi; Katrina Diener; Bifeng Gao; Kenneth Jones; Jing H Wang
Journal:  BMC Genomics       Date:  2016-10-21       Impact factor: 3.969

Review 8.  Know your enemy or find your friend?-Induction of IgA at mucosal surfaces.

Authors:  Mats Bemark; Davide Angeletti
Journal:  Immunol Rev       Date:  2021-07-30       Impact factor: 10.983

9.  Combined deletion of Xrcc4 and Trp53 in mouse germinal center B cells leads to novel B cell lymphomas with clonal heterogeneity.

Authors:  Zhangguo Chen; Mihret T Elos; Sawanee S Viboolsittiseri; Katherine Gowan; Sonia M Leach; Michael Rice; Maxwell D Eder; Kenneth Jones; Jing H Wang
Journal:  J Hematol Oncol       Date:  2016-01-07       Impact factor: 17.388

10.  Chemotherapy-induced differential cell cycle arrest in B-cell lymphomas affects their sensitivity to Wee1 inhibition.

Authors:  Xiaoguang Wang; Zhangguo Chen; Ameet K Mishra; Alexa Silva; Wenhua Ren; Zenggang Pan; Jing H Wang
Journal:  Haematologica       Date:  2017-12-07       Impact factor: 9.941

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.